3,605
Views
112
CrossRef citations to date
0
Altmetric
Original Research

Phase II study of the GPC3-derived peptide vaccine as an adjuvant therapy for hepatocellular carcinoma patients

, , , , , , , , , , , , , , , , , , , , & show all
Article: e1129483 | Received 28 Oct 2015, Accepted 30 Nov 2015, Published online: 31 May 2016